F. Hoffmann-La Roche Ltd - Company Profile
Powered by
All the data and insights you need on F. Hoffmann-La Roche Ltd in one report.
- Save hours of research time and resources with
our up-to-date F. Hoffmann-La Roche Ltd Strategy Report
- Understand F. Hoffmann-La Roche Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreF. Hoffmann-La Roche Catalyst Calendar
Proactively evaluate F. Hoffmann-La Roche Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of F. Hoffmann-La Roche Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Sep 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
31 Aug 2019 | Phase I Trial Completion | Chugai Pharmaceutical Co Ltd; F. Hoffmann-La Roche Ltd | 4519; ROG | balovaptan | Central Nervous System | Pervasive Developmental Disorder (PDD) | Clinical Trial Registry |
31 Aug 2019 | Phase I Trial Completion | Chugai Pharmaceutical Co Ltd; F. Hoffmann-La Roche Ltd | 4519; ROG | ralmitaront | Central Nervous System | Psychiatric Disorders | Clinical Trial Registry |
19 Aug 2019 | Phase IV Trial Initiation | Chugai Pharmaceutical Co Ltd; EP-CRSU Co Ltd | 4519 | emicizumab | Hematological Disorders | Hemophilia A (Factor VIII Deficiency) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer